Compare Gerdau S.A. Common Stock (GGB) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gerdau S.A. Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? Gerdau S.A. Common Stock trades at $5.12 (market cap $9.16B), while Relay Therapeutics Inc. Common Stock trades at $17.88 (market cap $3.82B). The key difference: Gerdau S.A. Common Stock is far larger — about 2.4× Relay Therapeutics Inc. Common Stock's market cap, and Gerdau S.A. Common Stock pays a 3.67% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gerdau S.A. Common Stock for 1 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| GGB | RLAY | |
|---|---|---|
Market Cap | $9.16B | $3.82B |
Volume | 16,238,936 | 4,332,079 |
Sector | Basic Materials | Health |
52-Week High | $5.17 | $20.75 |
52-Week Low | $3.15 | $6.03 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $11.10B | $2.93B |
Dividend Yield | 3.67% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Gerdau S.A. Common Stock
Gerdau is a steel producer with operations across the Americas. It makes long steel, specialty steel, and other products for construction and industrial markets.
Read more on GGB →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
